Track topics on Twitter Track topics that are important to you
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known whether intensity-modulated radiation therapy is more effective than external-beam radiation therapy in treating patients with early-stage endometrial cancer.
- To compare the incidence of grade 2 or higher acute genitourinary and gastrointestinal toxicity in patients with early-stage endometrial cancer treated with adjuvant pelvic radiotherapy comprising either intensity-modulated radiotherapy or 2-dimensional virtual-simulation planning.
- To compare the incidence of late genitourinary and gastrointestinal toxicity in these patients.
- To determine the feasibility of implementing pelvic nodal irradiation in gynecological cancer.
- To establish an image-guided pathway for gynecological cancer radiotherapy incorporating set-up errors and optimal margins for set-up uncertainty and investigation of effects of bladder filling and rectal preparation protocols on the planning target volume.
- To determine the rate of loco-regional control in these patients.
- To evaluate the quality of life of these patients.
- To determine the rate of disease-free survival of these patients
- To determine the overall survival of these patients.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
- Arm I (control): Patients undergo external-beam pelvic radiotherapy delivered using a 2-dimensional virtual-simulation planned technique followed by vaginal vault brachytherapy.
- Arm II (experimental): Patients undergo external-beam pelvic radiotherapy delivered using intensity-modulated radiotherapy followed by vaginal vault brachytherapy.
Patients complete quality of life questionnaires (EORTC QLQ C30 and EORTC QLQ Cervical Cancer Specific Module CX 24) at baseline, at the end of treatment, at 6 and 12 months, once a year for up to year 5, and then twice a year thereafter for up to year 10.
After completion of study treatment, patients are followed every 3 months for year 1, every 6 month for 1 year, and then once a year for up to 10 years.
Allocation: Randomized, Masking: Open Label, Primary Purpose: Treatment
questionnaire administration, adjuvant therapy, assessment of therapy complications, quality-of-life assessment, brachytherapy, external beam radiation therapy, intensity-modulated radiation therapy, radiation therapy treatment planning/simulation
Saint Luke's Hospital
National Cancer Institute (NCI)
Published on BioPortfolio: 2014-07-24T14:00:39-0400
The purpose of this study is to find out what patients consider when deciding whether or not to receive adjuvant treatment, and how patients feel about their decision after one year.
This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer. Androgens can cause the growth of prostate cancer cell...
This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a wa...
This randomized phase III trial studies how well gabapentin plus standard of care work compares to standard of care without Gabapentin in preventing inflammation of the mucous membranes (m...
With increasing survival rates, a growing population of patients with cancer have received or will receive adjuvant therapy to prevent cancer recurrences. Patients and caregivers will confront the com...
Steroid pulse therapy has shown satisfactory efficacy and safety in treating pemphigus vulgaris. However, there is a paucity of data about the efficacy and safety of methylprednisolone, despite its fr...
EndoPredict (EPclin) is a prognostic test validated to inform decisions on adjuvant chemotherapy to endocrine therapy alone for patients with oestrogen receptor-positive, HER2-negative breast cancer. ...
Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials.
Endocrine therapy with aromatase inhibitors (AIs) is the cornerstone of adjuvant systemic treatment for postmenopausal patients with hormone receptor-positive breast cancer. It has become clear that h...
The Functional Assessment of Chronic Illness Therapy (FACIT) is a measurement system that was developed to assess the health-related quality of life among patients with cancer and other chronic illnes...
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
The assessment, treatment, and management of soft tissue injury or dysfunction. Therapy is designed to reduce tension and irritation in affected tissues and may include MASSAGE; muscle stretching, or direct pressure on muscles, connective tissue, and TRIGGER POINTS.
The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...